Chitosan-Based Nano Systems for Natural Antioxidants in Breast Cancer Therapy

Area of Science:

• * Pharmacology
• * Nanotechnology
• * Oncology

Background:

• * Breast cancer is a leading global cause of death, with chemotherapy causing oxidative stress.
• * Natural antioxidants can mitigate chemotherapy side effects but often have poor oral bioavailability due to low solubility.
• * Chitosan-based nanoparticle (CSNP) systems offer a promising solution for enhancing antioxidant delivery.

Purpose of the Study:

• * To review methods for developing chitosan-based nanoformulations for oral delivery of natural antioxidants.
• * To explore how these nanoformulations improve pharmacokinetics and pharmacodynamics.
• * To understand the role of chitosan nanoparticles in stabilizing and enhancing antioxidant performance for cancer therapy.

Main Methods:

• * Review of literature on chitosan-based nanoparticle synthesis and formulation.
• * Analysis of pharmacokinetic and pharmacodynamic data for oral antioxidant delivery.
• * Examination of chitosan's properties as a drug delivery vehicle.

Main Results:

• * Chitosan-based nanoparticles significantly improve the water solubility and oral bioavailability of natural antioxidants.
• * Nanoformulation enhances the stability and therapeutic efficacy of antioxidants.
• * Chitosan nanoparticles demonstrate potential as effective carriers for cancer therapeutics.

Conclusions:

• * Chitosan-based nanoformulation is a viable strategy to overcome the limitations of oral natural antioxidants in cancer treatment.
• * Enhanced bioavailability and stability of antioxidants via CSNPs can improve cancer drug performance.
• * Further research into CSNPs can optimize cancer therapy and reduce chemotherapy side effects.